Discussion and Analysis (MD&A) for year 2017 (Revised) 11 Performance With reference to the aforementioned financial statements, the Company reports a consolidated net profit of THB 365 million and net loss of
position for the first quarter of 2018 with those of 2017. This report discusses principal changes in the unreviewed consolidated financial statements. Overall market environment The Thai economy for the
first quarter of 2018 with those of 2017. This report discusses principal changes in the reviewed consolidated financial statements. Overall market environment The Thai economy for the first quarter of
reduction for the purpose of reducing the deficit in the separate financial statements of the Company. 5 November 2018: U City’s ordinary and preferred shares start trading at new par value. The reverse stock
position for the second quarter and the first half of 2017 with those of 2016. This report discusses principal changes in the unaudited consolidated financial statements. Overall market environment The Thai
position for the second quarter and the first half of 2017 with those of 2016. This report discusses principal changes in the audited consolidated financial statements. Overall market environment The Thai
and financial position for the third quarter and the nine months ending September 30, 2017 with those of 2016. This report discusses principal changes in the unreviewed consolidated financial statements
and financial position for the third quarter and the nine months ending September 30, 2017 with those of 2016. This report discusses principal changes in the reviewed consolidated financial statements
insurance claim based on the terrorism risk protection for the amount of THB 3,500 mn (details available in Note 36: Other Events in the annual financial statements ended December 31, 2017). In 4Q17, CPN
statements. Overall market environment The Thai economy during the third quarter of 2018 continued to expand particularly from domestic demand. Private consumption grew mainly from the durable goods segment